T-CURX GmbH, a German CAR-T Cell Biotech Spin-Off from University of Würzburg, Appoints Ulf Grawunder as CEO
T-CURX, a German CAR-T cell Biotech spin-off from University of Würzburg, appoints Ulf Grawunder as CEO.
Source: b3cnewswire.com
Page 3 - Chimeric Antigen News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Chimeric Antigen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Chimeric Antigen Today - Breaking & Trending Today
Nektar and Collaborators Present Preclinical Data on NKTR-255, a Novel IL-15 Receptor Agonist, in combination with CAR Cell Therapies at the 2022 Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT™ and CIBMTR® - Press Release
SAN FRANCISCO, April 23, 2022 /PRNewswire/ -- Nektar Therapeutics NKTR announced that collaborators from the Cairo Laboratory at New York Medical Coll
Source: wiredprnews.com
Tessa Therapeutics Ltd: Tessa Therapeutics Announces Presentation of Autologous and Allogeneic Cell Therapy Data at 2021 ASH Annual Meeting
Presentations to feature clinical data from a Phase II CD30 CAR-T therapy study and a Phase I CD30 CAR-EBVST therapy study targeting lymphomasSINGAPORE, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Tessa Therapeutics
Source: finanznachrichten.de
Big Slick KC benefits families affected by pediatric cancer
Big Slick KC is helping families fighting childhood cancer.
Source: kshb.com
Chinese medical staff cure Pakistani and warm their hearts--China Economic Net
Mr. Anjum Iqbal, a Pakistani patient, and his wife take a photo with the medical staff of the Affiliated Hospital of Xuzhou Medical University, China.
Source: en.ce.cn